All News #Library
Rare Diseases
Oak Hill Bio Licenses Angelman Syndrome Treatment to Roche
15 Apr 2025 //
BUSINESSWIRE
Oak Hill Bio Promotes Josh Distler To Chief Executive Officer
07 Oct 2024 //
BUSINESSWIRE

Market Place
Sourcing Support